Abstract
The faecal flora of 21 patients with proctocolitis and five patients with Crohn's disease of the large bowel was examined both while sulphasalazine was being administered and during control periods. Patients with proctocolitis and Crohn's disease who were not receiving sulphasalazine had a similar flora which did not differ in any way from the normal. The effect of sulphasalazine was to decrease the numbers of opalescent-negative clostridia, enterobacteria, and total non-sporing anaerobes. It is suggested that this antibacterial effect of sulphasalazine, which has not been previously demonstrated, may be related to the beneficial effects of this drug in proctocolitis and should be investigated further.
MeSH Terms
Adrenal Cortex Hormones/administration & dosage
Adrenocorticotropic Hormone/therapeutic use
Adult
Aged
Bacteroides/isolation & purification
Clostridium/isolation & purification
Colitis/drug therapy,microbiology
Crohn Disease/drug therapy,microbiology
Enterobacteriaceae/isolation & purification
Eubacterium/isolation & purification
Feces/microbiology
Female
Humans
Intestine, Large/microbiology
Male
Middle Aged
Prednisone/therapeutic use
Proctitis/drug therapy
Sulfasalazine/therapeutic use
Chemicals
Adrenal Cortex Hormones
Sulfasalazine
Adrenocorticotropic Hormone
Prednisone
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
West B
Lendrum R
Hill M J
Walker G
References (18)
18 references, click to expand
-
Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.
Gut. 1969 Jul;10(7):565-8
PMID: 4390007
-
Bacteria and aetiology of cancer of large bowel.
Lancet. 1971 Jan 16;1(7690):95-100
PMID: 4099643
-
Transport and storage of faeces for bacteriological examination.
J Appl Bacteriol. 1971 Jun;34(2):477-83
PMID: 4939276
-
The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.
J Pharmacol Exp Ther. 1972 Jun;181(3):555-62
PMID: 4402374
-
Absorption, metabolism, and excretion of salicylazosulfapyridine in man.
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539-51
PMID: 4402886
-
Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.
Clin Pharmacol Ther. 1973 Sep-Oct;14(5):802-9
PMID: 4147120
-
The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.
Gut. 1973 Aug;14(8):631-41
PMID: 4147555
-
Azo reduction of salicyl-azo-sulphapyridine in germ-free and conventional rats.
Xenobiotica. 1973 Apr;3(4):225-31
PMID: 4147914
-
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).
Gut. 1973 Dec;14(12):923-6
PMID: 4150435
-
Properties of strains of Escherichia coli carried in different phases of ulcerative colitis.
Gut. 1974 Feb;15(2):143-6
PMID: 4595080
-
Proceedings: Effects on prostaglandin biosynthesis of drugs affecting gastrointestinal function.
Gut. 1974 Apr;15(4):344
PMID: 4151867
-
Bacteriologic aspects of ulcerative colitis.
Gastroenterology. 1961 Feb;40:323-30
PMID: 13783973
-
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.
Lancet. 1962 May 26;1(7239):1094-6
PMID: 13865153
-
Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.
Acta Med Scand. 1963 Jan;173:61-72
PMID: 13952555
-
CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.
Gut. 1964 Oct;5:437-42
PMID: 14218553
-
Cultivation of anaerobic intestinal bacteria.
J Pathol Bacteriol. 1967 Oct;94(2):417-27
PMID: 4864095
-
Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons.
J Pathol Bacteriol. 1968 Jan;95(1):101-13
PMID: 4868427
-
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.
Gastroenterology. 1968 Apr;54(4):575-87
PMID: 4385122